Literature DB >> 15664692

Increased gabaergic input to ventral tegmental area dopaminergic neurons associated with decreased cocaine reinforcement in mu-opioid receptor knockout mice.

D S Mathon1, H M B Lesscher, M A F M Gerrits, A Kamal, J E Pintar, A G P Schuller, B M Spruijt, J P H Burbach, M P Smidt, J M van Ree, G M J Ramakers.   

Abstract

There is general agreement that dopaminergic neurons projecting from the ventral tegmental area (VTA) to the nucleus accumbens and prefrontal cortex play a key role in drug reinforcement. The activity of these neurons is strongly modulated by the inhibitory and excitatory input they receive. Activation of mu-opioid receptors, located on GABAergic neurons in the VTA, causes hyperpolarization of these GABAergic neurons, thereby causing a disinhibition of VTA dopaminergic neurons. This effect of mu-opioid receptors upon GABA neurotransmission is a likely mechanism for mu-opioid receptor modulation of drug reinforcement. We studied mu-opioid receptor signaling in relation to cocaine reinforcement in wild-type and mu-opioid receptor knockout mice using a cocaine self-administration paradigm and in vitro electrophysiology. Cocaine self-administration was reduced in mu-opioid receptor knockout mice, suggesting a critical role of mu-opioid receptors in cocaine reinforcement. The frequency of spontaneous inhibitory post-synaptic currents onto dopaminergic neurons in the ventral tegmental area was increased in mu-opioid receptor knockout mice compared with wild-type controls, while the frequency of spontaneous excitatory post-synaptic currents was unaltered. The reduced cocaine self-administration and increased GABAergic input to VTA dopaminergic neurons in mu-opioid receptor knockout mice supports the notion that suppression of GABAergic input onto dopaminergic neurons in the VTA contributes to mu-opioid receptor modulation of cocaine reinforcement.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664692     DOI: 10.1016/j.neuroscience.2004.10.002

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  27 in total

1.  Modification of morphine-induced hyperlocomotion and antinociception in mice by clorgyline, a monoamine oxidase-A inhibitor.

Authors:  Nobue Kitanaka; Junichi Kitanaka; Motohiko Takemura
Journal:  Neurochem Res       Date:  2006-06-23       Impact factor: 3.996

Review 2.  The opioid receptors as targets for drug abuse medication.

Authors:  Florence Noble; Magalie Lenoir; Nicolas Marie
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

Review 3.  The endogenous opioid system in cocaine addiction: what lessons have opioid peptide and receptor knockout mice taught us?

Authors:  Ji Hoon Yoo; Ian Kitchen; Alexis Bailey
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

4.  Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite.

Authors:  Alfonso Abizaid; Zhong-Wu Liu; Zane B Andrews; Marya Shanabrough; Erzsebet Borok; John D Elsworth; Robert H Roth; Mark W Sleeman; Marina R Picciotto; Matthias H Tschöp; Xiao-Bing Gao; Tamas L Horvath
Journal:  J Clin Invest       Date:  2006-10-19       Impact factor: 14.808

5.  Acute cocaine exposure weakens GABA(B) receptor-dependent G-protein-gated inwardly rectifying K+ signaling in dopamine neurons of the ventral tegmental area.

Authors:  Devinder Arora; Matthew Hearing; Desirae M Haluk; Kelsey Mirkovic; Ana Fajardo-Serrano; Martin W Wessendorf; Masahiko Watanabe; Rafael Luján; Kevin Wickman
Journal:  J Neurosci       Date:  2011-08-24       Impact factor: 6.167

6.  Mu-opioid receptors selectively regulate basal inhibitory transmission in the central amygdala: lack of ethanol interactions.

Authors:  Maeng-Hee Kang-Park; Brigitte L Kieffer; Amanda J Roberts; Marisa Roberto; Samuel G Madamba; George Robert Siggins; Scott D Moore
Journal:  J Pharmacol Exp Ther       Date:  2008-10-14       Impact factor: 4.030

Review 7.  Reward processing by the opioid system in the brain.

Authors:  Julie Le Merrer; Jérôme A J Becker; Katia Befort; Brigitte L Kieffer
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

8.  Morphine withdrawal enhances constitutive μ-opioid receptor activity in the ventral tegmental area.

Authors:  Frank J Meye; Ruud van Zessen; Marten P Smidt; Roger A H Adan; Geert M J Ramakers
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

9.  Mu opioid receptor modulation of somatodendritic dopamine overflow: GABAergic and glutamatergic mechanisms.

Authors:  V I Chefer; L Denoroy; A Zapata; T S Shippenberg
Journal:  Eur J Neurosci       Date:  2009-07-15       Impact factor: 3.386

Review 10.  Implications of genome wide association studies for addiction: are our a priori assumptions all wrong?

Authors:  F Scott Hall; Jana Drgonova; Siddharth Jain; George R Uhl
Journal:  Pharmacol Ther       Date:  2013-07-18       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.